Studies

CellWell record HH-208019

Pharmacokinetics, Pharmacodynamics and Immunogenicity of AC02, a Novel Synthetic Derivate Peptide of Human Adrenocorticotropic Hormone for Infantile Spasms

Shunbo Zhao; Bingda Wu; Hui Shen; Qi Zhou; Minlu Cheng; Chang Shu; Li Ding

2026

In plain language

In this first-in-human trial, the synthetic ACTH-derived peptide AC02 showed dose-proportional pharmacokinetics and cortisol responses comparable to porcine ACTH1-39, with an acceptable safety profile.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-208019

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.